MedPage On the present time) — The FDA despatched 18 warning letters to web sites that illegally market unapproved and misbranded botulinum toxin (Botox) products, the company announced.
The letters had been addressed to sites with names fancy cosmo-korea.com, derma-resolution…
Study More
FDA’s Botox Warning Targets Web sites With Unapproved Products
More From Author
‘Rep the recordsdata and part the recordsdata:’ How can recreation companies pork up women with leadership ambitions?
